, /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)-- even on days when mealtime boluses were missed. CareLink™ data showed that the studied user population achieved 76.3% TIR on missed bolus days when using SmartGuard™ technology with recommended optimal settings (100 mg/dL glucose target; two-hour active insulin time).